MLAB Logo

Mesa Laboratories, Inc. (MLAB) Insider Trading Activity

NASDAQ$120.1
Market Cap
$652.58M
Sector
Technology
Industry
Hardware, Equipment & Parts
Rank in Sector
381 of 546
Rank in Industry
41 of 64

MLAB Insider Trading Activity

MLAB Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$0
0
0
Sells
$3,361,221
4
100

Related Transactions

Archbold Brian DavidSVP Operations
0
$0
1
$187,375
$-187,375
Owens Gary MPresident and CEO
0
$0
3
$3.17M
$-3.17M

About Mesa Laboratories, Inc.

Mesa Laboratories, Inc. develops, manufactures, and sells life sciences tools and quality control products and services in the United States, Europe, the Asia Pacific, and internationally. The company's Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators that are used to assess the effectiveness of sterilization and disinfection processes in the hospital, dental, medical device, and pharmaceutical industries. This segment also provides testing and laboratory services primarily to the dental industry. Its Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. This segment's solutions include protein analysis comprising analysis equipment, CDs, kits, and buffers; and peptide synthesizers that enables to automate chemically synthesized peptides that are used in the creation of peptide therapies, biomaterials, cosmetics, and general research. The company's Calibration Solutions segment designs, manufactures, and markets quality control and calibration products to measure or calibrate temperature, pressure, pH, humidity, and other such parameters used for health and safety purposes in the hospital, medical device manufacturing, pharmaceutical manufacturing, and various laboratory and healthcare environments. This segment's products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems. Its Clinical Genomics segment develops, manufactures, and sells genetic analysis tools that include MassARRAY system and consumables, including chips, panels, and chemical reagent solutions used by clinical labs to perform genomic clinical testing in several therapeutic areas, such as newborn screenings, pharmacogenetics, and oncology. The company was incorporated in 1982 and is headquartered in Lakewood, Colorado.

Insider Activity of Mesa Laboratories, Inc.

Over the last 12 months, insiders at Mesa Laboratories, Inc. have bought $0 and sold $3.36M worth of Mesa Laboratories, Inc. stock.

On average, over the past 5 years, insiders at Mesa Laboratories, Inc. have bought $100,000 and sold $9.07M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 500 shares for transaction amount of $100,000 was made by Tripeny R Tony () on 2022‑08‑09.

List of Insider Buy and Sell Transactions, Mesa Laboratories, Inc.

2025-03-19SaleOwens Gary MPresident and CEO
21,000
0.3855%
$123.91
$2.6M
-5.54%
2024-10-29SaleOwens Gary MPresident and CEO
2,551
0.0469%
$111.98
$285,651
+12.24%
2024-10-28SaleOwens Gary MPresident and CEO
2,518
0.0395%
$113.62
$286,085
+12.00%
2024-09-13SaleArchbold Brian DavidSVP Operations
1,499
0.0276%
$125.00
$187,375
+0.81%
2023-12-15SaleArchbold Brian DavidSVP Operations
1,500
0.0282%
$112.36
$168,540
-1.59%
2023-09-15SaleSchmieder John Bradleydirector
1,000
0.0187%
$123.74
$123,740
-15.56%
2023-09-14SaleSchmieder John Bradleydirector
3,000
0.0546%
$123.05
$369,150
-17.19%
2023-09-13SaleSchmieder John Bradleydirector
3,000
0.0559%
$123.32
$369,965
-15.24%
2023-09-01SaleOwens Gary MPresident and CEO
2,000
0.0378%
$142.82
$285,640
-26.10%
2023-03-24SaleSakys JohnCFO
1,128
0.0207%
$167.01
$188,387
-33.28%
2023-03-22SaleSakys JohnCFO
2,500
0.0475%
$171.62
$429,050
-31.98%
2023-03-15SaleSakys JohnCFO
1,000
0.0185%
$165.71
$165,710
-27.37%
2023-03-09SaleSakys JohnCFO
400
0.0074%
$169.97
$67,988
-28.54%
2023-02-09SaleSakys JohnCFO
1,000
0.0194%
$184.27
$184,270
-28.37%
2023-01-23SaleSakys JohnCFO
2,100
0.0409%
$210.19
$441,399
-35.20%
2023-01-13SaleSchmieder John Bradleydirector
1,571
0.0295%
$191.31
$300,548
-30.17%
2022-12-08SaleHall Shannondirector
230
0.0042%
$174.97
$40,244
-21.32%
2022-11-11SaleSchmieder John Bradleydirector
2,500
0.0455%
$175.45
$438,625
-12.33%
2022-08-18SaleGUILLEMIN EVAN
3,692
0.0685%
$196.12
$724,075
-16.71%
2022-08-16SaleSakys JohnCFO
1,372
0.0258%
$200.58
$275,196
-17.30%
Total: 250
*Gray background shows transactions not older than one year

Insider Historical Profitability

17.59%
Owens Gary MPresident and CEO
43337
0.7976%
$5.2M011
Archbold Brian DavidSVP Operations
0
0%
$0011
SEG Ventures, LLCdirector
200000
3.6808%
$24.02M40
SCHMIEDER LUKE Rdirector
172488
3.1745%
$20.72M02
DUKE PAUL Ddirector
70043
1.2891%
$8.41M011
Schmieder John Bradleydirector
62760
1.155%
$7.54M018
CAMPBELL H STUARTdirector
41527
0.7643%
$4.99M122
<0.0001%
Dwyer Robert Vdirector
35696
0.6569%
$4.29M226
GUILLEMIN EVAN
28776
0.5296%
$3.46M419
BROOKS MICHAEL Tdirector
27750
0.5107%
$3.33M04
Sullivan John Jamesdirector
23857
0.4391%
$2.87M535
PETERSON STEVEN W
21362
0.3931%
$2.57M09
Adriance Glenn ECSMO
10000
0.184%
$1.2M19
+36.2%
Sakys JohnCFO
9696
0.1784%
$1.16M029
DINOIA GREGORYSVP Commercial
3634
0.0669%
$436,443.4008
KELLY DAVID Mdirector
2600
0.0479%
$312,260.00314
+33.14%
Hall Shannondirector
957
0.0176%
$114,935.7001
Tripeny R Tony
500
0.0092%
$60,050.0010
<0.0001%
*Gray background shows insiders who have made transactions during last year

MLAB Institutional Investors: Active Positions

Increased Positions69+38.12%608,965+12.37%
Decreased Positions75-41.44%242,220-4.92%
New Positions9New279,329New
Sold Out Positions23Sold Out110,588Sold Out
Total Postitions175-3.31%5M+7.45%

MLAB Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Blackrock, Inc.$98,536.0016.55%827,616-16,748-1.98%2025-03-31
Conestoga Capital Advisors, Llc$68,026.0011.43%571,358-1,679-0.29%2025-03-31
Vanguard Group Inc$45,583.007.66%382,856+5,274+1.4%2024-12-31
Royce & Associates Lp$34,195.005.74%287,207-59,938-17.27%2024-12-31
Raymond James Financial Inc$29,502.004.96%247,795+247,795New2024-12-31
Morgan Stanley$28,637.004.81%240,526-8,822-3.54%2024-12-31
Ranger Investment Management, L.P.$27,807.004.67%233,555-4,635-1.95%2024-12-31
State Street Corp$26,777.004.5%224,901+10,753+5.02%2024-12-31
Geneva Capital Management Llc$22,504.003.78%189,013-2,963-1.54%2024-12-31
Eagle Asset Management Inc$19,759.003.32%165,955+16,293+10.89%2024-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.